Your browser doesn't support javascript.
loading
Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL.
Hagner, Patrick R; Chiu, Hsiling; Chopra, Vivek S; Colombo, Martino; Patel, Nisha; Estevez, Maria Ortiz; Waldman, Michelle F; Loos, Remco; Towfic, Fadi; Gandhi, Anita K.
Afiliação
  • Hagner PR; Bristol Myers Squibb, Summit, New Jersey.
  • Chiu H; Bristol Myers Squibb, Summit, New Jersey.
  • Chopra VS; Genentech, San Francisco, California.
  • Colombo M; Celgene Corporation, a Bristol Myers Squibb Company, Seville, Spain.
  • Patel N; Loxo Oncology, San Francisco, California.
  • Estevez MO; Celgene Corporation, a Bristol Myers Squibb Company, Seville, Spain.
  • Waldman MF; Bristol Myers Squibb, Summit, New Jersey.
  • Loos R; Celgene Corporation, a Bristol Myers Squibb Company, Seville, Spain.
  • Towfic F; Bristol Myers Squibb, Summit, New Jersey.
  • Gandhi AK; Bristol Myers Squibb, Summit, New Jersey.
Clin Cancer Res ; 28(15): 3367-3377, 2022 08 02.
Article em En | MEDLINE | ID: mdl-35583604
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Inibidores de Histona Desacetilases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Inibidores de Histona Desacetilases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article